Ultrasound-guided pO(2) measurement in breast cancer patients before and after hyperthermia treatment

por Vujaskovic, Z, Rosen, E, Blackwell, K, Jones, EL, Prosnitz, LP, Samulski, TW, Dewhirst, MW
Publicado 2001

Pooled analysis of two randomized, double-blind trials comparing proposed biosimilar LA-EP2006 with reference pegfilgrastim in breast cancer

por Blackwell, K., Gascon, P., Jones, C. M., Nixon, A., Krendyukov, A., Nakov, R., Li, Y., Harbeck, N.
Publicado 2017

Human recombinant erythropoietin (rEpo) has no effect on tumour growth or angiogenesis

por Hardee, M E, Kirkpatrick, J P, Shan, S, Snyder, S A, Vujaskovic, Z, Rabbani, Z N, Dewhirst, M W, Blackwell, K L
Publicado 2005

Comparison of EP2006, a filgrastim biosimilar, to the reference: a phase III, randomized, double-blind clinical study in the prevention of severe neutropenia in patients with breas...

por Blackwell, K., Semiglazov, V., Krasnozhon, D., Davidenko, I., Nelyubina, L., Nakov, R., Stiegler, G., Singh, P., Schwebig, A., Kramer, S., Harbeck, N.
Publicado 2015

Trastuzumab emtansine (T-DM1) versus lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer and central nervous system metastases: a retrospective, exp...

por Krop, I. E., Lin, N. U., Blackwell, K., Guardino, E., Huober, J., Lu, M., Miles, D., Samant, M., Welslau, M., Diéras, V.
Publicado 2015

Carbonic anhydrase IX is a predictive marker of doxorubicin resistance in early-stage breast cancer independent of HER2 and TOP2A amplification

por Betof, A S, Rabbani, Z N, Hardee, M E, Kim, S J, Broadwater, G, Bentley, R C, Snyder, S A, Vujaskovic, Z, Oosterwijk, E, Harris, L N, Horton, J K, Dewhirst, M W, Blackwell, K L
Publicado 2012

Updated results from MONALEESA-2, a phase III trial of first-line ribociclib plus letrozole versus placebo plus letrozole in hormone receptor-positive, HER2-negative advanced breas...

por Hortobagyi, G N, Stemmer, S M, Burris, H A, Yap, Y S, Sonke, G S, Paluch-Shimon, S, Campone, M, Petrakova, K, Blackwell, K L, Winer, E P, Janni, W, Verma, S, Conte, P, Arteaga, C L, Cameron, D A, Mondal, S, Su, F, Miller, M, Elmeliegy, M, Germa, C, O’Shaughnessy, J
Publicado 2019

ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)(†)

por Cardoso, F., Costa, A., Norton, L., Senkus, E., Aapro, M., André, F., Barrios, C. H., Bergh, J., Biganzoli, L., Blackwell, K. L., Cardoso, M. J., Cufer, T., El Saghir, N., Fallowfield, L., Fenech, D., Francis, P., Gelmon, K., Giordano, S. H., Gligorov, J., Goldhirsch, A., Harbeck, N., Houssami, N., Hudis, C., Kaufman, B., Krop, I., Kyriakides, S., Lin, U. N., Mayer, M., Merjaver, S. D., Nordström, E. B., Pagani, O., Partridge, A., Penault-Llorca, F., Piccart, M. J., Rugo, H., Sledge, G., Thomssen, C., van't Veer, L., Vorobiof, D., Vrieling, C., West, N., Xu, B., Winer, E.
Publicado 2014